Paula Krakowiak1,2, Paula E Goines3, Daniel J Tancredi4, Paul Ashwood2,5, Robin L Hansen2,6, Irva Hertz-Picciotto1,2, Judy Van de Water3,2. 1. Divisions of Epidemiology and of Environmental and Occupational Health, Department of Public Health Sciences, School of Medicine, University of California, Davis. 2. MIND (Medical Investigations of Neurodevelopmental Disorders) Institute, University of California, Davis. 3. Division of Rheumatology, Allergy and Clinical Immunology, Department of Internal Medicine, School of Medicine, University of California, Davis. 4. Department of Pediatrics, School of Medicine, University of California, Davis. 5. Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis. 6. Division of Developmental Behavioral Pediatrics, Department of Pediatrics, School of Medicine, University of California, Davis.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) is a complex neurodevelopmental condition that can be reliably diagnosed at age 24 months. Immunological phenomena, including skewed cytokine production, have been observed among children with ASD. Little is known about whether immune dysregulation is present before diagnosis of ASD. METHODS: We examined neonatal blood spots from 214 children with ASD (141 severe, 73 mild/moderate), 62 children with typical development, and 27 children with developmental delay as control subjects who participated in the Childhood Autism Risks from Genetics and the Environment study, a population-based case-control study. Levels of 17 cytokines and chemokines were compared across groups and in relation to developmental and behavioral domains. RESULTS: Interleukin (IL)-1β and IL-4 were independently associated with ASD compared with typical development, although these relationships varied by ASD symptom intensity. Elevated IL-4 was associated with increased odds of severe ASD (odds ratio [OR] = 1.40, 95% confidence interval [CI], 1.03, 1.91), whereas IL-1β was associated with increased odds of mild/moderate ASD (OR = 3.02, 95% CI, 1.43, 6.38). Additionally, IL-4 was associated with a higher likelihood of severe ASD versus mild/moderate ASD (OR = 1.35, 95% CI, 1.04, 1.75). In male subjects with ASD, IL-4 was negatively associated with nonverbal cognitive ability (β = -3.63, SE = 1.33, p = .04). CONCLUSIONS: This study is part of a growing effort to identify early biological markers for ASD. We demonstrate that peripheral cytokine profiles at birth are associated with ASD later in childhood and that cytokine profiles vary depending on ASD severity. Cytokines have complex roles in neurodevelopment, and dysregulated levels may be indicative of genetic differences and environmental exposures or their interactions that relate to ASD.
BACKGROUND:Autism spectrum disorder (ASD) is a complex neurodevelopmental condition that can be reliably diagnosed at age 24 months. Immunological phenomena, including skewed cytokine production, have been observed among children with ASD. Little is known about whether immune dysregulation is present before diagnosis of ASD. METHODS: We examined neonatal blood spots from 214 children with ASD (141 severe, 73 mild/moderate), 62 children with typical development, and 27 children with developmental delay as control subjects who participated in the Childhood Autism Risks from Genetics and the Environment study, a population-based case-control study. Levels of 17 cytokines and chemokines were compared across groups and in relation to developmental and behavioral domains. RESULTS: Interleukin (IL)-1β and IL-4 were independently associated with ASD compared with typical development, although these relationships varied by ASD symptom intensity. Elevated IL-4 was associated with increased odds of severe ASD (odds ratio [OR] = 1.40, 95% confidence interval [CI], 1.03, 1.91), whereas IL-1β was associated with increased odds of mild/moderate ASD (OR = 3.02, 95% CI, 1.43, 6.38). Additionally, IL-4 was associated with a higher likelihood of severe ASD versus mild/moderate ASD (OR = 1.35, 95% CI, 1.04, 1.75). In male subjects with ASD, IL-4 was negatively associated with nonverbal cognitive ability (β = -3.63, SE = 1.33, p = .04). CONCLUSIONS: This study is part of a growing effort to identify early biological markers for ASD. We demonstrate that peripheral cytokine profiles at birth are associated with ASD later in childhood and that cytokine profiles vary depending on ASD severity. Cytokines have complex roles in neurodevelopment, and dysregulated levels may be indicative of genetic differences and environmental exposures or their interactions that relate to ASD.
Authors: Amélie Piton; Jacques L Michaud; Huashan Peng; Swaroop Aradhya; Julie Gauthier; Laurent Mottron; Nathalie Champagne; Ronald G Lafrenière; Fadi F Hamdan; Ridha Joober; Eric Fombonne; Claude Marineau; Patrick Cossette; Marie-Pierre Dubé; Pejmun Haghighi; Pierre Drapeau; Philip A Barker; Salvatore Carbonetto; Guy A Rouleau Journal: Hum Mol Genet Date: 2008-09-18 Impact factor: 6.150
Authors: Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water Journal: Brain Behav Immun Date: 2010-08-10 Impact factor: 7.217
Authors: Morsi W Abdallah; Nanna Larsen; Erik L Mortensen; Hjördis Ó Atladóttir; Bent Nørgaard-Pedersen; Eva Cecilie Bonefeld-Jørgensen; Jakob Grove; David M Hougaard Journal: J Neuroimmunol Date: 2012-08-20 Impact factor: 3.478
Authors: Paula E Goines; Lisa A Croen; Daniel Braunschweig; Cathleen K Yoshida; Judith Grether; Robin Hansen; Martin Kharrazi; Paul Ashwood; Judy Van de Water Journal: Mol Autism Date: 2011-08-02 Impact factor: 7.509
Authors: Jessica L Irwin; Alison J Yeates; Maria S Mulhern; Emeir M McSorley; J J Strain; Gene E Watson; Katherine Grzesik; Sally W Thurston; Tanzy M Love; Tristram H Smith; Daniel W Mruzek; Conrad F Shamlaye; Catriona Monthy; Gary J Myers; Philip W Davidson; Edwin van Wijngaarden Journal: Mol Neurobiol Date: 2018-11-14 Impact factor: 5.590
Authors: Lisa A Croen; Yinge Qian; Paul Ashwood; Julie L Daniels; Daniele Fallin; Diana Schendel; Laura A Schieve; Alison B Singer; Ousseny Zerbo Journal: Autism Res Date: 2018-08-10 Impact factor: 5.216
Authors: Hanna C Gustafsson; Elinor L Sullivan; Elizabeth K Nousen; Ceri A Sullivan; Elaine Huang; Monica Rincon; Joel T Nigg; Jennifer M Loftis Journal: Brain Behav Immun Date: 2018-06-18 Impact factor: 7.217
Authors: Jared J Schwartzer; Milo Careaga; Morgan A Coburn; Destanie R Rose; Heather K Hughes; Paul Ashwood Journal: Brain Behav Immun Date: 2016-09-10 Impact factor: 7.217